CompletedPhase 1

The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.

United States30 participantsStarted 2021-02-24

Plain-language summary

A Randomized, Three Parallel Arms Clinical Trial to evaluate s the clinical impact of L-PRF vs H-PRF vs Palatal stent on the healing of the donor palatal site.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects between 18-65 years of age.
✓. Subjects need FGG or de-epithelialized Connective tissue graft
✓. Good oral hygiene (Plaque and bleeding indexes \<20%).
✓. Subjects can withstand alginate impression or wear a retainer.
✓. No other surgery or need for analgesics at the same site.

Exclusion criteria

✕. Subjects with any systemic disorders that might compromise wound healing (Uncontrolled diabetes mellitus, rheumatoid arthritis, osteoporosis, chemotherapy/radiotherapy and immunological disorders).
✕. Smokers
✕. Patients not maintaining oral hygiene (plaque score \>20%)
✕. Pregnant or breastfeeding females.
✕. Inability to provide informed consent.
✕. Grafts thickness more than 2mm will be excluded from the study.

What they're measuring

The Clinical Impact of L-PRF, H-PRF, or the Use of a Surgical Stent on Palatal Donor Site Healing.

Timeframe: 5 days

The Clinical Impact of L-PRF, H-PRF, or the Use of a Surgical Stent on Palatal Donor Site Healing.

Timeframe: 10 days

The Clinical Impact of L-PRF, H-PRF, or the Use of a Surgical Stent on Palatal Donor Site Healing.

Timeframe: 14 days

The Clinical Impact of L-PRF, H-PRF, or the Use of a Surgical Stent on Palatal Donor Site Healing.

Timeframe: 21 days

Trial details

NCT IDNCT04758702

SponsorAbdo Y Ismail

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-25

View on ClinicalTrials.gov More Lack of Keratinized Gingiva trials